• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, June 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Amphetamine use, abuse and dependence claim lines increased over 3,000 percent in 10 years

Bioengineer by Bioengineer
December 18, 2018
in Health
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Anxiety claim lines rose over 200 percent, FAIR Health study shows

IMAGE

Credit: FAIR Health


NEW YORK, NY–December 18, 2018–Private insurance claim lines for amphetamine use, abuse and dependence increased 3,157 percent from 2007 to 2017, according to a new behavioral health study by FAIR Health, a national, independent, nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information. Amphetamines include medications frequently used to treat attention-deficit/hyperactivity disorder (e.g., Ritalin), narcolepsy and obesity. Utilization of privately billed medical services for anxiety increased 242 percent in the same period.

The initial study results are shown in the infographic. FAIR Health is preparing a more expansive white paper on behavioral health (mental health and substance use disorders) from 2007 to 2017, to be released in the coming months.

The period from 2007 to 2017 marks the time from just before and since the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (Mental Health Parity Act). That law required most group health plans that cover physical and behavioral health to provide the same level of coverage for behavioral services as for medical and surgical services. FAIR Health data show that private insurance claim lines for behavioral health diagnoses increased 320 percent overall from 2007 to 2017.

The FAIR Health study is based on an analysis of data from its repository of over 27 billion claim records from 2002 to the present, the nation’s largest collection of private healthcare claims. Among the findings:

  • Claim lines with diagnoses of use, abuse and dependence of the following substances increased from 2007 to 2017 by these percentages:
    • Barbiturates–2,233 percent;
    • Hallucinogens–2,055 percent; and
    • Cannabis–585 percent.
  • Claim lines with the following diagnoses increased from 2007 to 2017 by these percentages:
    • Post-traumatic stress disorder (PTSD)–177 percent;
    • Major depressive disorder–172 percent;
    • Bipolar disorder–103 percent;
    • Obsessive-compulsive disorder (OCD)–65 percent; and
    • Adjustment disorders (including those with anxiety and depression)–65 percent.

FAIR Health President Robin Gelburd stated: “Behavioral health is vital to overall health, and the decade since enactment of the Mental Health Parity Act has seen significant growth in utilization of behavioral healthcare. Our ongoing study is poised to assist policy makers, researchers and others in understanding and improving the nation’s behavioral health.”

###

Click here for the infographic.

Follow us on Twitter @FAIRHealth

About FAIR Health

FAIR Health is a national, independent, nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information through data products, consumer resources and health systems research support. FAIR Health possesses the nation’s largest collection of private healthcare claims data, which includes over 27 billion claim records contributed by payors and administrators who insure or process claims for private insurance plans covering more than 150 million individuals. FAIR Health licenses its privately billed data and data products–including benchmark modules, data visualizations, custom analytics, episodes of care analytics and market indices–to commercial insurers and self-insurers, employers, providers, hospitals and healthcare systems, government agencies, researchers and others. FAIR Health also holds separate data representing the experience of all individuals enrolled in traditional Medicare from 2013 to the present (as well as Medicare Advantage enrollees represented in its private claims data). Certified by the Centers for Medicare & Medicaid Services (CMS) as a Qualified Entity, FAIR Health receives all of Medicare Parts A, B and D claims data for use in nationwide transparency efforts. FAIR Health can produce insightful analytic reports and data products based on combined Medicare and commercial claims data for government, providers, payors and other authorized users. FAIR Health has earned HITRUST CSF and Service Organization Controls (SOC 2) certifications by meeting the rigorous data security requirements of these standards. As a testament to the reliability and objectivity of FAIR Health data, the data have been incorporated in statutes and regulations around the country and designated as the official, neutral data source for a variety of state health programs, including workers’ compensation and personal injury protection (PIP) programs. FAIR Health data serve as an official reference point in support of certain state balance billing laws that protect consumers against bills for surprise out-of-network and emergency services. FAIR Health also uses its database to power a free consumer website available in English and Spanish and an English/Spanish mobile app, which enable consumers to estimate and plan their healthcare expenditures and offer a rich educational platform on health insurance. The website has been honored by the White House Summit on Smart Disclosure, the Agency for Healthcare Research and Quality (AHRQ), URAC, the eHealthcare Leadership Awards, appPicker, Employee Benefit News and Kiplinger’s Personal Finance. FAIR Health also is named a top resource for patients in Elisabeth Rosenthal’s book, An American Sickness: How Healthcare Became Big Business and How You Can Take It Back. For more information on FAIR Health, visit fairhealth.org.

Contact:

Dean Sicoli

Executive Director of Communications and Government Relations

FAIR Health

646-664-1645

[email protected]

Media Contact
Dean Sicoli
[email protected]
646-664-1645

Original Source

https://www.fairhealth.org/press-release-preview/amphetamine-use-abuse-and-dependence-claim-lines-increased-over-3-000-percent-in-10-years

Tags: AddictionBehaviorHealth CareHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthMental HealthPainPublic HealthSocial/Behavioral Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Perivascular Fluid Diffusivity Predicts Early Parkinson’s Decline

Perivascular Fluid Diffusivity Predicts Early Parkinson’s Decline

June 14, 2025
Rewrite Excitation-inhibition balance abnormally shapes structure–function coupling of gray matter in Parkinson’s disease as a headline for a science magazine post, using no more than 8 words

Rewrite Excitation-inhibition balance abnormally shapes structure–function coupling of gray matter in Parkinson’s disease as a headline for a science magazine post, using no more than 8 words

June 13, 2025

Rewrite Repurposing the memory-promoting meclofenoxate hydrochloride as a treatment for Parkinson’s disease through integrative multi-omics analysis as a headline for a science magazine post, using no more than 8 words

June 13, 2025

Rewrite Myelin–axon interface vulnerability in Alzheimer’s disease revealed by subcellular proteomics and imaging of human and mouse brain as a headline for a science magazine post, using no more than 8 words

June 13, 2025
Please login to join discussion

POPULAR NEWS

  • Green brake lights in the front could reduce accidents

    Study from TU Graz Reveals Front Brake Lights Could Drastically Diminish Road Accident Rates

    158 shares
    Share 63 Tweet 40
  • New Study Uncovers Unexpected Side Effects of High-Dose Radiation Therapy

    75 shares
    Share 30 Tweet 19
  • Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    68 shares
    Share 27 Tweet 17
  • How Scientists Unraveled the Mystery Behind the Gigantic Size of Extinct Ground Sloths—and What Led to Their Demise

    65 shares
    Share 26 Tweet 16
v>

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Perivascular Fluid Diffusivity Predicts Early Parkinson’s Decline

Are Traditional Podcasters Becoming Obsolete? AI-Driven Podcasts Pave the Way for Accessible Science

Rewrite The untranslatability of environmental affective scales: insights from indigenous soundscape perceptions in China as a headline for a science magazine post, using no more than 8 words

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.